The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 6, Pages e68252
Publisher
Public Library of Science (PLoS)
Online
2013-06-28
DOI
10.1371/journal.pone.0068252
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance
- (2013) M Dietel et al. CANCER GENE THERAPY
- Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations
- (2012) B. Weigelt et al. ANNALS OF ONCOLOGY
- Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
- (2012) Ralf Kronenwett et al. BMC CANCER
- Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay
- (2012) Carsten Denkert et al. VIRCHOWS ARCHIV
- Prospective transGEICAM study of the impact of the 21-gene Recurrence Score assay and traditional clinicopathological factors on adjuvant clinical decision making in women with estrogen receptor-positive (ER+) node-negative breast cancer
- (2011) J. Albanell et al. ANNALS OF ONCOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
- (2011) Martin Filipits et al. CLINICAL CANCER RESEARCH
- Quantitative Determination of Estrogen Receptor, Progesterone Receptor, and HER2 mRNA in Formalin-fixed Paraffin-embedded Tissue—A New Option for Predictive Biomarker Assessment in Breast Cancer
- (2011) Berit Maria Müller et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2010) S. Aebi et al. ANNALS OF ONCOLOGY
- Automated Extraction of DNA and RNA from a Single Formalin-Fixed Paraffin-Embedded Tissue Section for Analysis of Both Single-Nucleotide Polymorphisms and mRNA Expression
- (2010) G. Hennig et al. CLINICAL CHEMISTRY
- Prospective Multicenter Study of the Impact of the 21-Gene Recurrence Score Assay on Medical Oncologist and Patient Adjuvant Breast Cancer Treatment Selection
- (2010) Shelly S. Lo et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast cancer assessment tools and optimizing adjuvant therapy
- (2010) Catherine Oakman et al. Nature Reviews Clinical Oncology
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- RNA Extraction from Archival Formalin-Fixed Paraffin-Embedded Tissue: A Comparison of Manual, Semiautomated, and Fully Automated Purification Methods
- (2009) K. Bohmann et al. CLINICAL CHEMISTRY
- Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
- (2009) R. M. Simon et al. JNCI-Journal of the National Cancer Institute
- Early breast cancer
- (2009) John R Benson et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now